Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D - Wikidata - awgldk - TriplyDB

Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D

Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D

http://www.wikidata.org/entity/Q33801022

about

Tip-toeing toward the finish line.Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.Sudden cardiac death in South India: Incidence, risk factors and pathology.Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease.Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease.A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients.

P2860

Q34865383-08BF4E23-E992-4862-A482-EFAEC2EBACFE Q35209016-F8C839DB-9A73-49F7-BFE2-5E9DB7665AA9 Q37542044-B96A08BC-5806-4ED4-953D-7B5D04F6CE6F Q38210438-037BFBBB-ADC0-41C8-94C1-C30E69D0374D Q38567745-0F6E9D57-1B57-49F8-987C-2AAC8AC5BD7F Q38741675-4D80EA7C-2731-4366-A02F-E85ECB611A09 Q55347421-E0471966-5243-414D-8675-0BCFC0E39058

P2860

Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D

http://www.wikidata.org/entity/Q33801022

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@ast

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@en

type

label

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@ast

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@en

prefLabel

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@ast

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@en

P1433

Q33801022-C74B6BB6-6CCE-4DAB-B377-2DCE9065D499

P1476

Q33801022-60726749-F09E-462A-A16F-D7F415D48231

P2093

Q33801022-43A75E64-91C8-42B4-A409-86959587AEF3

Q33801022-49341EA3-E1FF-4D4C-A22A-49D9CA14A0F7

P2860

Q33801022-13FD60C6-B323-42C3-A8ED-46F110F416F9

Q33801022-1E49CF50-B0E2-4020-B888-49806B84013A

Q33801022-24CDB619-BB5D-4346-87B8-C85A81AD025B

Q33801022-2C8036FB-372C-418B-9C63-1E8649394484

Q33801022-2F5FB1F6-7089-4321-B6B0-632C79A01B46

Q33801022-34C40C16-1F04-4926-B26F-FC082D2E9354

Q33801022-35CFC996-7323-4432-B67D-0CD949A03463

Q33801022-3664E2F3-1923-4CC1-B718-935B2054E304

Q33801022-42A82C22-8F96-4AF8-841F-B4E692E90DEC

Q33801022-56427F25-5B22-4701-A423-7130E25D77FC

P304

Q33801022-B105D849-5462-495E-91B8-D11AD7BCF2FF

P31

Q33801022-14B03C98-6D0F-4778-AF30-7303ADCEB5C8

P356

Q33801022-45F94431-54BE-4954-A57C-58A56D00DE4C

P433

Q33801022-2CEB88CC-211C-47E9-92CE-B3E69E6800F2

P478

Q33801022-A866CB21-0CC5-4BA9-A436-D2091D970896

P50

Q33801022-0649D0B9-72CA-4C4E-99F8-A19D0C854E0C

P577

Q33801022-310B146A-E4A1-4893-97D8-E539B098A65E

P698

Q33801022-47BA2974-9BD1-4574-99FB-10E086203BF1

P932

Q33801022-30CB1C59-EE2B-4996-8259-04F78C4C3A72

P356

J.AJKD.2013.11.015

P1433

American Journal of Kidney Diseases

P1476

Comparative effectiveness of c ...... ts enrolled in Medicare part D

@en

P2093

Akeem A Yusuf

http://www.w3.org/2001/XMLSchema#string

Eric D Weinhandl

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of the association between adherence to drug therapy and mortality

Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients

A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.

Identifying persons with diabetes using Medicare claims data.

Phosphorus binders and survival on hemodialysis.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Indications for propensity scores and review of their use in pharmacoepidemiology.

Effects of phosphate binders in moderate CKD

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients.

P304

95-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2013.11.015

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24387795

http://www.w3.org/2001/XMLSchema#string

P932

4069228

http://www.w3.org/2001/XMLSchema#string